Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

IIROC Trade Resumption - NVC

Canada NewsWire December 23, 2016

IIROC Trade Resumption - Neovasc Inc.

Newsfile December 23, 2016

Neovasc Announces Update in Litigation with CardiAQ

Canada NewsWire December 23, 2016

IIROC Trading Halt - NVC

Canada NewsWire December 23, 2016

IIROC Trade Halt - Neovasc Inc.

Newsfile December 23, 2016

IIROC Trade Resumption - NVC

Canada NewsWire December 20, 2016

IIROC Trading Halt - NVC

Canada NewsWire December 20, 2016

IIROC Trade Resumption - Neovasc Inc.

Newsfile December 20, 2016

IIROC Trade Halt - Neovasc Inc.

Newsfile December 20, 2016

Neovasc Regains Compliance with NASDAQ Listing Requirements

PR Newswire December 19, 2016

18 Biggest Mid-Day Losers For Wednesday

Benzinga.com  December 14, 2016

10 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  December 13, 2016

Mid-Morning Market Update: Markets Open Higher; VeriFone Issues Weak Forecast

Benzinga.com  December 13, 2016

20 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  December 13, 2016

Neovasc and Boston Scientific Close US$75 Million Agreement

Canada NewsWire December 13, 2016

Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc, Inc.

PR Newswire December 13, 2016

Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data

Benzinga.com  December 7, 2016

Mid-Afternoon Market Update: U.S. Stocks Edge Higher; Intralinks Shares Climb On Acquisition News

Benzinga.com  December 6, 2016

18 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  December 6, 2016

Neovasc Provides Update on its Tiara™ Mitral Valve Clinical Program

Canada NewsWire December 6, 2016